Drug development process market ppt powerpoint presentation file pictures

Description:

The image depicts the second part of a two-part presentation slide series detailing the drug development process, from initial discovery to market launch. This particular slide focuses on the latter stages including preclinical development, clinical development, approval, and market release.

1. In the "Drug Discovery" phase, it mentions the start of the process with ~10,000 compounds, highlighting key activities such as target identification, receptor binding, occupancy, time on target, and drug target.

2. In "Preclinical Development," with ~250 compounds, the activities become more refined and include proof of mechanism, species differences, pharmacokinetics/pharmacodynamics (PK/PD), ADME (absorption, distribution, metabolism, and excretion), safety, dose ranging, drug delivery, efficacy, and clinical validation. This stage typically takes 3&6 years.

3. "Clinical Development" is the next phase with more rigorous testing on ~5 compounds, divided into various phases (Phase 0 microdosing to Phase I&III trials), focusing on efficacy, safety, human PK, dose selection, and bioavailability, and this phase lasts about 6 & 7 years.

4. The "Approval" stage filters down to 1 compound and is represented by a checkmark, signifying successful regulatory approval.

5. Finally, the "Market" stage is shown by an icon depicting a shopping bag, indicating the drug has been launched to the public. This stage involves Phase IV trials, safety, efficacy, diagnosis, staging, treatment planning and monitoring, prognosis, post-marketing surveillance, and competitive advantage. This can usually take about 0.5& 2 years.

A note is added stating, "In this slide a user can add his drug development phases and components along with years," indicating the template's interactive nature for customization.

Use Cases:

This comprehensive outline could have tangible applications across various industries involved in healthcare and pharmaceuticals.

1. Pharmaceuticals:

Use: Training on drug development process

Presenter: R&D Training Coordinator

Audience: Research Scientists & New Employees

2. Biotechnology:

Use: Investor presentations on product pipelines

Presenter: Chief Scientific Officer

Audience: Investors & Stakeholders

3. Medical Education:

Use: Academic teaching about drug development

Presenter: Professor or Lecturer

Audience: Medical and Pharmacy Students

4. Healthcare Consulting:

Use: Consulting on pharmaceutical product life cycles

Presenter: Healthcare Consultant

Audience: Pharma Executives & Decision Makers

5. Regulatory Affairs:

Use: Understanding the approval process for new drugs

Presenter: Regulatory Affairs Specialist

Audience: Regulatory Affairs Teams & Policy Makers

6. Investment Banking:

Use: Financial analysis of pharmaceutical companies

Presenter: Investment Analyst

Audience: Institutional Investors & Financial Advisors

7. Clinical Research Organizations:

Use: Overview of clinical trial phase services

Presenter: Clinical Project Manager

Audience: Pharmaceutical Clients & Clinical Research Associates